26066-15-9

Basic information

• Product Name: 3-ISO-PROPOXYBENZYL ALCOHOL
• Synonyms: 3-ISO-PROPOXYBENZYL ALCOHOL;BenzeneMethanol, 3-(1-Methylethoxy)-
• CAS NO: 26066-15-9
• Molecular Formula: C₁₀H₁₄O₂
• Molecular Weight: 166.22
• Mol File: 26066-15-9.mol

Chemical Properties

• Boiling Point: 271.6±15.0 °C(Predicted)
• Appearance: /
• Density: 1.034±0.06 g/cm3(Predicted)
• PKA: 14.37±0.10(Predicted)
• CAS DataBase Reference: 3-ISO-PROPOXYBENZYL ALCOHOL(CAS DataBase Reference)
• NIST Chemistry Reference: 3-ISO-PROPOXYBENZYL ALCOHOL(26066-15-9)
• EPA Substance Registry System: 3-ISO-PROPOXYBENZYL ALCOHOL(26066-15-9)

Safety Data

• Hazardous Substances Data: 26066-15-9(Hazardous Substances Data)

Usage

Uses

Used in Fragrance Industry:
3-ISO-PROPOXYBENZYL ALCOHOL is used as a fragrance ingredient for its ability to impart a sweet, floral scent to various consumer products such as perfumes, colognes, and cosmetics. It enhances the overall fragrance profile, adding depth and complexity to scents.
Used in Personal Care Products:
In the personal care industry, 3-ISO-PROPOXYBENZYL ALCOHOL is used as a component in the manufacturing process to provide a pleasant scent and improve the sensory experience of using these products.
Used in Household Cleaners:
3-ISO-PROPOXYBENZYL ALCOHOL is also utilized in the production of household cleaners, where it serves to add a fresh, floral fragrance, making the cleaning experience more enjoyable for consumers.
Used as a Solvent in Industrial Applications:
Beyond its aromatic applications, 3-ISO-PROPOXYBENZYL ALCOHOL can act as a solvent, finding use in various industrial processes where its solvent properties are required for the manufacturing or processing of different products.

Upstream product

• 100-83-4 meta-hydroxybenzaldehyde 
• 620-24-6 3-Hydroxybenzyl alcohol 
• 75-26-3 isopropyl bromide 
• 350989-42-3 methyl 3-isopropoxybenzoate 
• 75-30-9 2-iodo-propane 
• 75792-33-5 3-isopropoxybenzaldehyde 

Downstream Products

• 84640-29-9 3-isopropoxybenzyl N,N-dimethylcarbamate 
• 1202576-70-2 (3A) Ethyl 3-ethoxy-3-{4-[(3-isopropyloxybenzyl)oxy]phenyl}propionate 
• 1428640-06-5 methyl (2-bromo-5-isopropoxyphenyl)methanol 
• 1428640-07-6 1-bromo-2-(chloromethyl)-4-isopropoxybenzene 
• 1428640-08-7 methyl 5-(2-bromo-5-isopropoxybenzyloxy)-2'-fluorobiphenyl-2-carboxylate 
• 1428640-09-8 methyl 3-(2-fluorophenyl)-8-isopropoxy-6H-benzo[c]chromene-2-carboxylate 
• 1428640-10-1 methyl 3-(2-fluorophenyl)-8-hydroxy-6H-benzo[c]chromene-2-carboxylate 
• 1595658-06-2 C₁₁H₁₆O₄S 
• 1609009-49-5 5-amino-1-(3'-isopropoxybenzyl)-1H-1,2,3-triazole-4-carboxamide 
• 1609009-24-6 3-(3-isopropoxybenzyl)-5-methyl-3H-[1,2,3]triazolo[4,5-d]pyrimidin-7(6H)-one 
• 1609009-48-4 1-(azidomethyl)-3-isopropoxybenzene 
• 921599-50-0 (5R,7S)-4-(cyclohexylamino)-1-(3-fluorophenyl)-8-(3-isopropoxybenzyl)-7-methyl-1,3,8-triazaspiro[4.5]dec-3-en-2-one 
• 1428639-45-5 3-(2-fluorophenyl)-N₂-((R)-1-hydroxy-3-(1H-indol-3-yl)propan-2-yl)-N₈,N₈-dimethyl-6H-benzo[c]chromene-2,8-dicarboxamide 
• 1428640-17-8 8-(dimethylcarbamoyl)-3-(2-fluorophenyl)-6H-benzo[c]chromene-2-carboxylic acid 

Relevant articles and documents

Methyl-substitution of an iminohydantoin spiropiperidine β-secretase (BACE-1) inhibitor has a profound effect on its potency

The IC50 of a beta-secretase (BACE-1) lead compound was improved ～200-fold from 11 μM to 55 nM through the addition of a single methyl group. Computational chemistry, small molecule NMR, and protein crystallography capabilities were used to com

FSH RECEPTOR ANTAGONISTS

The invention relates to FSH receptor antagonist according to general formula I or a pharmaceutically acceptable salt thereof and to a pharmaceutical composition containing the same. The compounds can be used for the treatment and prevention of endometriosis, for the treatment and prevention of pre-menopausal and peri-menopausal hormone-dependent breast cancer, for contraception, and for the treatment of uterine fibroids and other menstrual-related disorders.

NOVEL PHENYL-ISOXAZOL-3-OL DERIVATIVE

The present invention relates to a compound represented by formula (I), which has a GPR120 agonist action and thus is useful for treatment of diabetes mellitus or hyperlipidemia, or a pharmaceutically acceptable salt thereof. In the formula, (AA) represents a phenyl or the like, which may be substituted with a lower alkoxy group or the like; (BB) represents a divalent group or the like, derived by removal of two hydrogen atoms from a benzene which may be substituted with a halogen atom or the like; X represents a spacer having a main chain composed of 1-8 carbon atoms wherein 1-3 carbon atoms in the main chain may be substituted with an oxygen atom or the like; and Y represents a hydrogen atom or the like.

SPIROPIPERIDINE BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE

The present invention is directed to spiropiperidine compounds of formula (I) and tautomers thereof, which are inhibitors of the beta-secretase enzyme and that are useful in the treatment of diseases in which the beta-secretase enzyme is involved, such as

1-BENZYLINDOLE-2-CARBOXAMIDE DERIVATIVES

The present invention relates to i-benzylindole-2-carboxamide derivatives of formula I, or a pharmaceutically acceptable salt or solvate thereof. The invention also relates to pharmaceutical compositions comprising said 1-benzylindole-2-carboxamide deriva

SPIROPIPERIDINE COMPOUNDS USEFUL AS BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHERMER’S DISEASE

The present invention is directed to spiropiperidine compounds of formula (I) which are inhibitors of the beta-secretase enzyme and that are useful in the treatment of diseases in which the beta-secretase enzyme is involved, such as Alzheimer's disease. T

Substituted 6,11-ethano-6,11-dihydrobenzo[b] quinolizinium salts and compositions and methods of use thereof

Substituted 6,11-ethano-6,11-dihydrobenzo[b]quinolizinium salts, pharmaceutical compositions containing them, and methods for the treatment of neurodegenerative disorders or neurotoxic injuries utilizing them, wherein the substituted 6,11-ethano-6,11-dihydrobenzo[b]quinolizinium salts have the formula: STR1 wherein: R1, R2, R3, R4, R5, R6, R7, X and p are as defined in the specification.